Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Urogen Pharma (URGN)
NASDAQ:URGN
Urogen Pharma (URGN) Ownership - Who Owns Urogen Pharma?
401 Followers
Urogen Pharma (URGN) Ownership Overview
10.84% Insiders
2.72% Mutual Funds
46.79% Other Institutional Investors
39.64% Public Companies and
Individual Investors
The ownership structure of Urogen Pharma (URGN) stock is a mix of institutional, retail and individual investors. Approximately 49.51% of the company’s stock is owned by Institutional Investors, 10.84% is owned by Insiders and 39.64% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 20, 2024 | Sold | $168600 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Sold | $2422875 | |
| Dec 31, 2023 | Bought | $46251450 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,083,430 | Institution | 9.04% | 44,678,901 | |
| 1,223,055 | Institution | 3.58% | 17,722,067 | |
| 495,606 | Institution | 1.45% | 7,181,331 | |
| 292,490 | Institution | 0.86% | 4,238,180 | |
| 161,585 | Institution | 0.47% | 2,341,367 | |
| 161,525 | Institution | 0.47% | 2,340,497 | |
| 156,576 | Institution | 0.46% | 2,268,786 | |
| 155,000 | Institution | 0.45% | 2,245,950 | |
| 147,739 | Institution | 0.43% | 2,140,738 | |
| 78,094 | Institution | 0.23% | 1,131,582 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 292,490 | Institution | 0.86% | 4,238,180 | |
| 155,000 | Institution | 0.45% | 2,245,950 | |
| 78,094 | Institution | 0.23% | 1,131,582 | |
| 71,342 | Institution | 0.21% | 1,033,746 | |
| 62,880 | Institution | 0.18% | 911,131 | |
| 46,963 | Institution | 0.14% | 680,494 | |
| 30,122 | Institution | 0.09% | 436,468 | |
| 25,083 | Institution | 0.07% | 363,453 | |
| 20,705 | Institution | 0.06% | 300,015 | |
| 19,633 | Institution | 0.06% | 284,482 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 665,928 | Institution | 1.95% | 9,649,297 | |
| 208,971 | Institution | 0.61% | 3,027,990 | |
| 194,015 | Institution | 0.57% | 2,811,277 | |
| 142,099 | Institution | 0.42% | 2,059,015 | |
| 116,021 | Institution | 0.34% | 1,751,917 | |
| 103,697 | Institution | 0.30% | 1,555,455 | |
| 60,702 | Institution | 0.18% | 879,572 | |
| 46,532 | Institution | 0.14% | 674,249 | |
| 31,841 | Institution | 0.09% | 480,799 | |
| 24,528 | Institution | 0.07% | 370,373 |
FAQ
Who Owns Urogen Pharma (URGN)?
According to the latest TipRanks data, approximately 46.79% of the company's stock is held by institutional investors, 10.84% is held by insiders, and 39.64% is held by retail investors.
What percentage of Urogen Pharma (URGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 46.79% of Urogen Pharma (URGN) stock is held by institutional investors.
What percentage of Urogen Pharma (URGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.64% of Urogen Pharma (URGN) stock is held by retail investors.
Who owns the most shares of Urogen Pharma (URGN)?
Peter Kolchinsky owns the most shares of Urogen Pharma (URGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.